Illegal Activity
none
Blackmail
none
Date
2014-2015
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:41
Summary
This email from EVS Equity on behalf of Deutsche Bank provides an analysis of Gilead's tax rate and valuation, projecting a 2015 EPS of $7.75/sh and valuing GILD at $5132/sh. The analysis considers the impact of Sovaldi sales and generic Sustiva on Gilead's financial performance.
Metadata
- Subject
- Gilead (GILD) Tax Rate Analysis and Valuation
- Sender
- EVS Equity
- Recipients
- —
- Document ID
- DB-SDNY-0101259, SDNY_GM_00247443
- Date
- 2014-2015
Relationships 3
| Entity 1 | Relationship | Entity 2 | Description |
|---|---|---|---|
| Gilead (GILD) | Financial Analysis | Deutsche Bank | Deutsche Bank provides equity research and valuation of Gilead. |
| Evalueserve | Service Provider | Deutsche Bank | Evalueserve sends the email on behalf of Deutsche Bank. |
| Tazia Smith | Employment | Deutsche Bank Securities Inc | Tazia Smith is a Director at Deutsche Bank Securities Inc. |
Notable Quotes 2
Gilead still remains our top pick in large cap
we value GILD at 5132/sh using 17x 2015 multiple (10% discount to its biotech peers due to patent cliff on base biz). our new '15 EPS is 57.75/sh.
Financial Information
Amounts:5132/sh57.75/sh10c
Assets:
- Gilead (GILD) stock
- Sovaldi sales
- Sustiva royalty payments
Transactions:
- Tax rate analysis for Gilead (GILD)
- Valuation of GILD at 5132/sh using 17x 2015 multiple
- Estimation of '14 tax rate at 23% decreasing to 18% over time if sovaldi hits revenue estimate
- Calculation of 2014 tax rate at -23.5%
- Implied sovaldi tax rate at -13%
- Weighted avg. tax rate for 2015 at -21%
Public Knowledge
- Context
- Financial analysis of a publicly traded company is often of interest to the media.
- Media Worthy
- Yes
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flowBusiness dealings
Organizations 5
Gilead (GILD)Deutsche BankEvalueserveDeutsche Bank Securities IncDeutsche Asset & wealth Management
Locations 4
EuropeUSNew York, NY345 Park Avenue, 26th Floor, New York, NY 10154
Financial Entities 1
Deutsche Bank
Text Analysis
- Tone
- Professional
- Purpose
- To provide an analysis of Gilead's tax rate and valuation, including the impact of Sovaldi sales and generic Sustiva.
- Significance
- The document provides financial analysis and projections for Gilead, a large-cap biotech company, focusing on tax rates, revenue estimates, and valuation.
File Info
- File Name
- EFTA01446853.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:41:07.850398
- DOJ Source
- View on DOJ